MyFinsight
Home
Blog
About
Contact
Download
Download image
Indefinite-lived intangible
assets
$17,811M
Finite-lived intangible
assets, net
$33,513M
Other current assets
$2,358M
Current tax assets
$3,855M
Inventories
$11,468M
Trade accounts
receivable, net of allowance...
$14,260M
Short-term investments
$13,641M
Cash and cash
equivalents
$1,343M
Other noncurrent
assets
$9,317M
Noncurrent deferred tax
assets and other...
$11,048M
Goodwill
$69,101M
Identifiable intangible
assets, net
$51,324M
Property, plant and
equipment, net of...
$18,880M
Long-term investments
$2,137M
Total current assets
$46,924M
Total assets
$208,731M
Total liabilities and
equity
$208,731M
Total equity
$93,096M
Total liabilities
$115,635M
Equity attributable to
noncontrolling interests
$295M
Total pfizer inc.
shareholders equity
$92,801M
Other noncurrent
liabilities
$13,605M
Other taxes payable
$3,401M
Noncurrent deferred tax
liabilities
$2,467M
Pension and
postretirement benefit...
$2,157M
Long-term debt
$57,409M
Total current
liabilities
$36,596M
Accumulated other
comprehensive loss
-$8,066M
Treasury stock
$115,011M
Retained earnings
$121,150M
Other current
liabilities
$19,509M
Deferred revenues
$924M
Accrued compensation
and related items
$3,036M
Income taxes payable
$3,799M
Trade accounts
payable
$5,024M
Short-term borrowings,
including current portion...
$4,303M
Additional paid-in capital
$94,248M
Common stock
$481M
Back
Back
Balance Sheet
source: myfinsight.com
Pfizer_(2021)-svg
PFIZER INC (PFE)
Pfizer_(2021)-svg
PFIZER INC (PFE)